
EVerZom, a French biopharma company focused on exosome-based therapies, has announced it has received €3m in funding as part of …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

